This is a working overview of GHRH analog, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-04 and is reviewed periodically as new material appears.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Amino acid length | 44 residues | Matches the native peptide backbone |
| Molecular weight | Approximately 5135 Da | Calculated from the peptide sequence |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
| Primary studied use | Visceral fat reduction | Investigated in HIV-associated lipodystrophy |
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
Science and Industry 2 - It was released on July 3, 2008 as a sequel to the GoldSrc mod. The gameplay is similar to the previous mod where the main objective is to capture enemy NPC scientists while defending your own. Synergy - A cooperative mod. Synergy supports official campaigns by Valve, user-made levels, and other third-party mods (MINERVA, City 7, and Riot Act). In September 2008, Valve introduced it as one of the first five Source mods being offered on Steam and supported by Steamworks. Team Fortress 2 Classified - A Team Fortress 2 mod that reimagines the game using its 2008-2009 incarnation as a base, adding new weapons, maps, and game modes. Zombie Panic! Source - A team-based zombie themed mod which pits player-controlled survivors against player-controlled zombies. The gameplay style simulates an outbreak: The zombie team starts with only a few players, but their ranks grow as survivors are defeated and switch to the zombie team. Its first public release was on December 28, 2007, and it received the Mod DB, players' choice, top unreleased mod award for 2007.
=== Automated culturing systems === Automatic cell culturing systems are becoming popular because of their ability to maintain a sterile growth environment and remove strain on the laboratory staff involving repetitive experimentation. Laboratories can also set incubation times to adjust for the lag period involved in bacterial growth.
In addition, it was also concerned with the "modernization" of productive structures, through an ambitious program of "industrial reconversion". Obsolete or ruinous companies were closed and credits were given to companies to introduce the necessary technological improvements to make them more competitive, among other measures. The most affected sectors were the steel and shipbuilding industries, especially the large public companies inherited from Franco's regime. Not coincidentally, it was in these sectors where the most important conflicts took place, with a proliferation of clashes between workers and the forces of public order, the most serious being those of Sagunto. This program was accompanied by heavy investments in infrastructure ─ thanks mainly to the European funds that arrived after the entry into the EEC ─ which allowed Spain to equip itself with a network of highways and freeways and to start the construction of the first high-speed rail line between Madrid and Seville that started operations in 1992. The positive effects of the economic policy started to show after 1985, when the Spanish economy began a strong expansion that would last until 1992. However, during those years there was also an increase in speculative capital movements led by people linked to the world of finance who were looking for easy enrichment.
Sources: en.wikipedia.org
Ownership of the shroud passed from the House of Savoy to the Catholic Church after the death of the former king Umberto II of Italy in 1983. The microscopist and forensic expert Walter McCrone found, based on his examination of samples taken in 1978 from the surface of the shroud using adhesive tape, that the image on the shroud had been painted with a dilute solution of red ochre pigment in a gelatin medium. McCrone also found that the apparent bloodstains were painted with vermilion pigment, also in a gelatin medium. McCrone's findings were disputed by other researchers, and the nature of the image on the shroud continues to be debated. In 1988, radiocarbon dating by three independent laboratories established that the shroud dates back to the Middle Ages, between 1260 and 1390. The nature and history of the shroud have been the subjects of extensive and long-lasting controversies in both the scholarly literature and the popular press. Although the radiocarbon dating of the shroud is accepted as valid by experts, it continues to generate significant public debate. Defenders of the authenticity of the shroud have questioned the radiocarbon results, usually on the basis that the samples tested might have been contaminated or taken from a repair to the original fabric. Such fringe theories, which have been rejected by most experts, include the medieval repair theory, the bio-contamination theories and the carbon monoxide theory. Currently, the Catholic Church neither endorses nor rejects the authenticity of the shroud as a relic of Jesus.
Female cultivars include 'Liberty Splendor', 'Santa Cruz', and 'Golden Girl', the latter so named because of the striking yellow color of its leaves in the fall; all female cultivars release zero pollen. Many cultivars are listed in the literature in the UK, of which the compact 'Troll' has gained the Royal Horticultural Society's Award of Garden Merit. Ginkgos adapt well to the urban environment, tolerating pollution and confined soil spaces. They rarely have disease problems, even in urban conditions, and are attacked by few insects. Ginkgos are popular subjects for growing as miniature landscapes known as penjing and bonsai; they can be kept artificially small and tended over centuries. The trees are easy to propagate from seed.
=== Laboratory tests === Serum creatine kinase (CK) is the most commonly used biomarker of muscle injury, and is often supplemented by aldolase, lactate dehydrogenase and the aminotransferases. However, elevated CK is not specific to myopathy, and isolated raised CK ("hyperCKemia") has a poor diagnostic yield on its own. Where an idiopathic inflammatory myopathy is suspected, testing for myositis-specific autoantibodies (MSAs) is recommended, ideally before starting immunosuppression, as these antibodies define distinct clinical subtypes and patterns of organ involvement.
Sources: en.wikipedia.org
=== Laboratory solvent === It is a common solvent for the Grignard reaction in addition to other reactions involving organometallic reagents. These uses exploit its basicity. Diethyl ether is a popular non-polar solvent in liquid-liquid extraction. As an extractant, it is immiscible with and less dense than water. Although immiscible, it has significant solubility in water (6.05 g/(100 ml) at 25 °C) and dissolves 1.5 g/(100 g) (1.0 g/(100 ml)) water at 25 °C.
=== Development of de novo sequencing algorithms === An old method is to list all possible peptides for the precursor ion in mass spectrum, and match the mass spectrum for each candidate to the experimental spectrum. The possible peptide that has the most similar spectrum will have the highest chance to be the right sequence. However, the number of possible peptides may be large. For example, a precursor peptide with a molecular weight of 774 has 21,909,046 possible peptides. Even though it is done in the computer, it takes a long time. Another method is called "subsequencing", which instead of listing whole sequence of possible peptides, matches short sequences of peptides that represent only a part of the complete peptide. When sequences that highly match the fragment ions in the experimental spectrum are found, they are extended by residues one by one to find the best matching. In the third method, graphical display of the data is applied, in which fragment ions that have the same mass differences of one amino acid residue are connected by lines. In this way, it is easier to get a clear image of ion series of the same type. This method could be helpful for manual de novo peptide sequencing, but doesn't work for high-throughput condition. The fourth method, which is considered to be successful, is the graph theory. Applying graph theory in de novo peptide sequencing was first mentioned by Bartels. Peaks in the spectrum are transformed into vertices in a graph called "spectrum graph".
==== Chain stores ==== Chain stores did not become popular in the United States until the end of World War I. It was reported in 1929 that chain stores accounted for 39% of all grocery sales in the United States. Chain stores' success is related to their ability to undersell smaller distributors. An anti-chain movement arose in response to the success of the chain stores during the Great Depression, but caused little detriment to the success and profitability of the chains.
Sources: en.wikipedia.org
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.
The synthetic peptide incorporates modifications that slow enzymatic breakdown in circulation. Native growth hormone-releasing hormone is short-lived, whereas the analog is designed for greater stability. The core amino acid backbone is largely retained.
The main studied application is reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. Research has measured fat changes through imaging. Findings concern fat distribution rather than overall body weight.
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.